Baseline characteristics of patients from ongoing post‐marketing surveillance, evaluating the real‐world efficacy and safety of edaravone, a novel, free radical scavenger, for amyotrophic lateral sclerosis patients in Japan (SUNRISE Japan)
2006 ◽
Vol 7
(4)
◽
pp. 247-251
◽
Keyword(s):
2016 ◽
Vol 17
(15)
◽
pp. 1985-1994
◽
Keyword(s):
2005 ◽
Vol 25
(1_suppl)
◽
pp. S30-S30
Keyword(s):
Keyword(s):